These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28624659)

  • 1. Surface engineering of Solid Lipid Nanoparticle assemblies by methyl α-d-mannopyranoside for the active targeting to macrophages in anti-tuberculosis inhalation therapy.
    Maretti E; Costantino L; Rustichelli C; Leo E; Croce MA; Buttini F; Truzzi E; Iannuccelli V
    Int J Pharm; 2017 Aug; 528(1-2):440-451. PubMed ID: 28624659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newly synthesized surfactants for surface mannosylation of respirable SLN assemblies to target macrophages in tuberculosis therapy.
    Maretti E; Costantino L; Buttini F; Rustichelli C; Leo E; Truzzi E; Iannuccelli V
    Drug Deliv Transl Res; 2019 Feb; 9(1):298-310. PubMed ID: 30484257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid Lipid Nanoparticle assemblies (SLNas) for an anti-TB inhalation treatment-A Design of Experiments approach to investigate the influence of pre-freezing conditions on the powder respirability.
    Maretti E; Rustichelli C; Romagnoli M; Balducci AG; Buttini F; Sacchetti F; Leo E; Iannuccelli V
    Int J Pharm; 2016 Sep; 511(1):669-679. PubMed ID: 27473279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Lipid Corona on Rifampicin Intramacrophagic Transport Using Inhaled Solid Lipid Nanoparticles Surface-Decorated with a Mannosylated Surfactant.
    Maretti E; Rustichelli C; Lassinantti Gualtieri M; Costantino L; Siligardi C; Miselli P; Buttini F; Montecchi M; Leo E; Truzzi E; Iannuccelli V
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31581554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vivo Biodistribution of Respirable Solid Lipid Nanoparticles Surface-Decorated with a Mannose-Based Surfactant: A Promising Tool for Pulmonary Tuberculosis Treatment?
    Truzzi E; Nascimento TL; Iannuccelli V; Costantino L; Lima EM; Leo E; Siligardi C; Gualtieri ML; Maretti E
    Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32245153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.
    Maretti E; Rossi T; Bondi M; Croce MA; Hanuskova M; Leo E; Sacchetti F; Iannuccelli V
    Int J Pharm; 2014 Feb; 462(1-2):74-82. PubMed ID: 24374224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mannose-functionalized solid lipid nanoparticles are effective in targeting alveolar macrophages.
    Costa A; Sarmento B; Seabra V
    Eur J Pharm Sci; 2018 Mar; 114():103-113. PubMed ID: 29229273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannosylated solid lipid nanoparticles for the selective delivery of rifampicin to macrophages.
    Vieira ACC; Chaves LL; Pinheiro M; Lima SAC; Ferreira D; Sarmento B; Reis S
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):653-663. PubMed ID: 29433346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M.tuberculosis killing efficiency.
    Pi J; Shen L; Shen H; Yang E; Wang W; Wang R; Huang D; Lee BS; Hu C; Chen C; Jin H; Cai J; Zeng G; Chen ZW
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109777. PubMed ID: 31349400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted macrophages delivery of rifampicin-loaded lipid nanoparticles to improve tuberculosis treatment.
    Vieira AC; Magalhães J; Rocha S; Cardoso MS; Santos SG; Borges M; Pinheiro M; Reis S
    Nanomedicine (Lond); 2017 Dec; 12(24):2721-2736. PubMed ID: 29119867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity screening of emulsifiers for pulmonary application of lipid nanoparticles.
    Steiner V; Öhlinger K; Corzo C; Salar-Behzadi S; Fröhlich E
    Eur J Pharm Sci; 2019 Aug; 136():104968. PubMed ID: 31233864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Rifampicin and Isoniazid Mannose-Decorated Lipopolysaccharide Nanospheres for Macrophage- Targeted Lung Delivery.
    Sumaila M; Kumar P; Ubanako P; Adeyemi SA; Choonara YE
    Curr Drug Deliv; 2023; 20(10):1487-1503. PubMed ID: 35959905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of encapsulated functional lipids on crystal structure and chemical stability in solid lipid nanoparticles: Towards bioactive-based design of delivery systems.
    Salminen H; Gömmel C; Leuenberger BH; Weiss J
    Food Chem; 2016 Jan; 190():928-937. PubMed ID: 26213058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
    Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
    Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis.
    Rawal T; Kremer L; Halloum I; Butani S
    J Aerosol Med Pulm Drug Deliv; 2017 Dec; 30(6):388-398. PubMed ID: 28510480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal structural design of mannosylated nanocarriers for macrophage targeting.
    Chen P; Zhang X; Jia L; Prud'homme RK; Szekely Z; Sinko PJ
    J Control Release; 2014 Nov; 194():341-9. PubMed ID: 25220160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Aminophenyl-α-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain.
    Singh I; Swami R; Jeengar MK; Khan W; Sistla R
    Chem Phys Lipids; 2015 May; 188():1-9. PubMed ID: 25819559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PstS-1, the 38-kDa Mycobacterium tuberculosis glycoprotein, is an adhesin, which binds the macrophage mannose receptor and promotes phagocytosis.
    Esparza M; Palomares B; García T; Espinosa P; Zenteno E; Mancilla R
    Scand J Immunol; 2015 Jan; 81(1):46-55. PubMed ID: 25359607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.
    Song X; Lin Q; Guo L; Fu Y; Han J; Ke H; Sun X; Gong T; Zhang Z
    Pharm Res; 2015 May; 32(5):1741-51. PubMed ID: 25407545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Miltefosine-loaded lipid nanoparticles: Improving miltefosine stability and reducing its hemolytic potential toward erythtocytes and its cytotoxic effect on macrophages.
    da Gama Bitencourt JJ; Pazin WM; Ito AS; Barioni MB; de Paula Pinto C; Santos MA; Guimarães TH; Santos MR; Valduga CJ
    Biophys Chem; 2016 Oct; 217():20-31. PubMed ID: 27497059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.